China Universal Asset Management Company’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.2M Sell
19,498
-1,863
-9% -$1.27M 0.73% 33
2026
Q1
$16.5M Buy
21,361
+1,608
+8% +$1.23M 1.25% 19
2025
Q4
$15.2M Sell
19,753
-1,606
-8% -$1.09M 1.17% 19
2025
Q3
$12M Sell
21,359
-3,178
-13% -$1.8M 0.99% 19
2025
Q2
$12.9M Sell
24,537
-1,092
-4% -$609K 1.21% 15
2025
Q1
$16.3M Buy
25,629
+955
+4% +$657K 1.51% 12
2024
Q4
$17.6M Buy
24,674
+9,908
+67% +$8.32M 1.64% 12
2024
Q3
$15.5M Buy
14,766
+5,216
+55% +$5.8M 1.71% 11
2024
Q2
$10M Sell
9,550
-6,506
-41% -$6.31M 1.42% 16
2024
Q1
$15.5M Buy
16,056
+5,758
+56% +$5.48M 1.96% 9
2023
Q4
$9.04M Buy
10,298
+7,351
+249% +$6.05M 1.76% 9
2023
Q3
$2.43M Buy
2,947
+1,413
+92% +$1.11M 0.7% 40
2023
Q2
$1.1M Buy
1,534
+45
+3% +$34.7K 0.34% 75
2023
Q1
$1.22M Buy
1,489
+401
+37% +$302K 0.41% 65
2022
Q4
$785K Buy
1,088
+85
+8% +$62.7K 0.32% 76
2022
Q3
$691K Buy
+1,003
New +$631K 0.29% 71

Other funds holding REGN

China Universal Asset Management Company's REGN Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Regeneron Pharmaceuticals (REGN) stake by 8.7% in Q2 2026, selling an estimated $1.27M and leaving 19,498 shares worth $12.2M. The position accounts for 0.73% of the portfolio, ranked #33.

China Universal Asset Management Company first reported a position in REGN in Q3 2022 and has held it in 16 quarters since. The position peaked at $17.6M in Q4 2024. 396 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • China Universal Asset Management Company held 19,498 shares of Regeneron Pharmaceuticals worth $12.2M as of Q2 2026.
  • China Universal Asset Management Company sold 1,863 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.27M.
  • Regeneron Pharmaceuticals made up 0.73% of China Universal Asset Management Company's portfolio in Q2 2026, its #33 holding.
  • China Universal Asset Management Company first reported a position in Regeneron Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Regeneron Pharmaceuticals position peaked at $17.6M in Q4 2024.
  • 396 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.